Use of monoclonal antibodies in the treatment of ovarian cancer.

Current opinion in obstetrics & gynecology

Volumn 22, Issue 1, 2010, Pages 3-8

  Mabuchi, Seiji ^a   Morishige, Kenichirou ^a   Kimura, Tadashi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CA 125 ANTIGEN; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HER2 PROTEIN, HUMAN; MONOCLONAL ANTIBODY; MUC1 PROTEIN, HUMAN; MUCIN 1; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

DRUG ANTAGONISM; FEMALE; HUMAN; OVARY TUMOR; REVIEW;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CA-125 ANTIGEN; FEMALE; HUMANS; MUCIN-1; OVARIAN NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77951240238     PISSN: None     EISSN: 1473656X     Source Type: Journal    
DOI: 10.1097/gco.0b013e3283324114     Document Type: Review

References (60)